A Weapon in a Bull Market, Poison in a Bear Market… Why Leverage is Fatal / Today's Foreign Buying Decides the Fate of the Stock Market | Lee Gwon-hee CEO

Watch on YouTube ↗  |  July 21, 2026 at 05:00  |  17:18  |  815 Money Talk (815머니톡)
Speakers
Lee Kwon-hee — CEO, Economist

Summary

Lee Kwon-hee, CEO of WizWave, discusses the investment outlook for Korean memory chips, shipbuilding, and Samsung Biologics. He sees AI capex supporting Samsung Electronics and SK hynix, views shipbuilders and marine engines as undervalued, and approves Samsung Biologics' latest M&A. He also highlights Micron as a beneficiary of strong free cash flow and warns against leveraged ETFs. The market is in a wait-and-see mode ahead of Big Tech earnings, with foreign futures buying providing a near-term upside signal.

  • KOSPI and NASDAQ futures have decoupled; Korean market now leads NASDAQ futures intraday.
  • AI capex cycle remains intact, benefiting Korean memory names Samsung and SK hynix, with Big Tech earnings as catalysts.
  • Shipbuilding and marine engine stocks (Hanwha Ocean, HD Hyundai Heavy Industries, Hanwha Engine, STX Engine) are seen as deeply undervalued after heavy sell-offs despite strong earnings and order books.
  • Samsung Biologics' acquisition of Polypeptide Group is a positive strategic move to expand CDMO capacity for GLP-1 drugs.
  • Micron is attractive due to expected dividend hikes and superior free cash flow, prompting a rotation call.
  • 2x leveraged ETFs are dangerous due to decay, with the speaker relaying a strong avoidance recommendation from an investment manager.
  • Today's KOSPI direction will depend on foreign buying in futures and whether Samsung/SK hynix close positive.
Ideas
Lee Kwon-hee CEO, Economist 0:38
Buy Korean memory on AI capex
Korean memory chipmakers Samsung Electronics and SK hynix are poised for a rebound as AI Capex remains robust. Big Tech earnings this week (Google, Amazon, Meta, Microsoft) are expected to show continued investment increases, and the absence of pre-announcements suggests results may be solid. The stocks are considered cheap after heavy sell-offs, and buying on dips is recommended.
Lee Kwon-hee CEO, Economist 2:33
Shipbuilders and engines are undervalued
Korean shipbuilding and marine engine stocks are significantly undervalued after giving back all their recent gains. Order books remain strong and earnings are robust: Hanwha Ocean's operating margin is projected to rise from 13% this year to 15-16% next year, HD Hyundai Heavy Industries is forecast to hit 20%. The sharp sell-off creates an attractive entry, and the sector should eventually re-rate upwards.
Lee Kwon-hee CEO, Economist 4:42
M&A expands GLP-1 CDMO capacity
Samsung Biologics' acquisition of the Polypeptide Group for 2.7 trillion won is a strategically positive move. The target is a 70-year-old CDMO with approved manufacturing facilities in five countries, producing peptide-based active ingredients for GLP-1 drugs. The deal expands Samsung Biologics' capabilities and positions it well in the growing obesity/diabetes drug supply chain, warranting a bullish view.
Lee Kwon-hee CEO, Economist 12:11
Micron dividend hike and strong FCF
Micron Technology is emerging as a favored memory play, driven by expectations of a massive dividend increase and strong free cash flow. Amid market uncertainty, investors may rotate from Big Tech into Micron for its cash‑rich profile and shareholder returns, making it a compelling long.
Up Next

This 815 Money Talk (815머니톡) video, published July 21, 2026, features Lee Kwon-hee discussing 005930.KS, 000660.KS, 329180.KS, 077970.KS, 082740.KS, 042660.KS, 207940.KS, MU. 4 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Kwon-hee  · Tickers: 005930.KS, 000660.KS, 329180.KS, 077970.KS, 082740.KS, 042660.KS, 207940.KS, MU